The hard work is only just beginning for scientists developing a vaccine. At the west London office of the drug giant GSK, there is a special unit for global planning on flu pandemic vaccines.
A special sample of the swine flu or H1N1 virus has arrived at GSK in the past week, allowing scientists to begin a detailed analysis.
The UK medical director, Dr Pim Kon, told the six-month process has many uncertainties. Although the company has agreed to provide 60m doses of a vaccine, it is not yet known how many people that will cover.
The Health Protection Agency recorded more than 60 new cases alone on Tuesday, and although nobody has yet died from the virus, experts are warning against any complacency.
A special sample of the swine flu or H1N1 virus has arrived at GSK in the past week, allowing scientists to begin a detailed analysis.
The UK medical director, Dr Pim Kon, told the six-month process has many uncertainties. Although the company has agreed to provide 60m doses of a vaccine, it is not yet known how many people that will cover.
The Health Protection Agency recorded more than 60 new cases alone on Tuesday, and although nobody has yet died from the virus, experts are warning against any complacency.
No comments:
Post a Comment